AWARENESS OF USING RINGER LACTAT SOLUTION IN DENGUE VIRUS INFECTION CASES COULD INDUCE SEVERITY
Downloads
Background: In 2012, serotype of Dengue Virus had changed from Den-2 and Den-3 to Den-1. In 5–10 years ago, serotype of Den-1 case showed a mild clinical manifestation; but now as a primary case it can also show severe clinical manifestation. One of indicator is an increasing liver enzyme, AST and ALT, with level more than 100–200 U/L. Aim: To getting a better solutions for this problem. Method: Obsevasional Study had been done in medical faculty of Airlangga University (Dr. Soetomo and Soerya hospital) Surabaya on Mei–August 2012. There were 10 cases of dengue virus infection were studied, 5 cases got Ringer Acetate solution (Group A) and 5 cases got Ringer Lactate solution (Group B). The diagnosis was based on criteria WHO 2009. Result: Five cases of Dengue Virus Infection had showed a liver damage soon after using Ringer Lactate solution; AST and ALT were increasing more than 100–200 U/L;
but the other 5 cases showed better condition. It might be due to use Ringer Acetate that did not have effect for inducing liver damage. By managing carefully, all of the cases had shown full recovery and healthy condition when being discharged. Conclusion: Using Ringer Acetate as fluid therapy in Dengue Virus Infection is better to prevent liver damage than using Ringer Lactate.
Indonesian Journal of Tropical and Infectious Disease by Institute of Tropical Disease, Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Permissions beyond the scope of this license may be available at http://e-journal.unair.ac.id/index.php/IJTID/. Both authors and Indonesian Journal of Tropical and Infectious Disease agree with the following attribution of journal:
1. Indonesian Journal of Tropical and Infectious Disease (IJTID) agrees to acknowledge the authors' articles published in Open Journal Access of IJTID
2. The authors agree to acknowledge Indonesian Journal of Tropical and Infectious Disease as the site of original publication of the articles
3. As the authors agree to publish their articles in IJTID, the copyright of the articles is fully transferred to IJTID.
4. The Creative Commons Attribution-ShareAlike 4.0 International licensing applied in IJTID allows IJTID share and adapt the articles by giving appropriate credit and distributing them to the readers for free under the same license.
Articles submitted in IJTID should include the "Copyright Transfer Agreement" preceding the article publication. Authors can download the "Copyright Transfer Agreement" for the purpose of publication.